Skip to main content
Top
Published in: Journal of Clinical Immunology 4/2024

Open Access 01-04-2024 | COVID-19 | Original Article

COVID-19 Vaccination in Patients with Inborn Errors of Immunity Reduces Hospitalization and Critical Care Needs Related to COVID-19: a USIDNET Report

Authors: John McDonnell, Kimberley Cousins, M. Elizabeth M. Younger, Adam Lane, Hassan Abolhassani, Roshini S. Abraham, Salem Al-Tamemi, Juan Carlos Aldave-Becerra, Eman Hesham Al-Faris, Alberto Alfaro-Murillo, Suzan A. AlKhater, Nouf Alsaati, Alexa Michelle Altman Doss, Melissa Anderson, Ernestina Angarola, Barbara Ariue, Danielle E. Arnold, Amal H. Assa’ad, Caner Aytekin, Meaghan Bank, Jenna R. E. Bergerson, Jack Bleesing, John Boesing, Carolina Bouso, Nicholas Brodszki, Diana Cabanillas, Carol Cady, Meghan A. Callahan, Roberta Caorsi, Javier Carbone, Maria Carrabba, Riccardo Castagnoli, Jason R. Catanzaro, Samantha Chan, Sharat Chandra, Hugo Chapdelaine, Zahra Chavoshzadeh, Hey Jin Chong, Lori Connors, Filippo Consonni, Oscar Correa-Jimenez, Charlotte Cunningham-Rundles, Katherine D’Astous-Gauthier, Ottavia Maria Delmonte, Yesim Yilmaz Demirdag, Deepti R. Deshpande, Natalie M. Diaz-Cabrera, Victoria R. Dimitriades, Rasha El-Owaidy, Gehad ElGhazali, Suleiman Al-Hammadi, Giovanna Fabio, Astrid Schellnast Faure, Jin Feng, James M. Fernandez, Lauren Fill, Guacira R. Franco, Robert W. Frenck, Ramsay L. Fuleihan, Giuliana Giardino, Jessica Galant-Swafford, Eleonora Gambineri, Elizabeth K. Garabedian, Ashley V. Geerlinks, Ekaterini Goudouris, Octavio Grecco, Qiang Pan-Hammarström, Hedieh Haji Khodaverdi Khani, Lennart Hammarström, Nicholas L. Hartog, Jennifer Heimall, Gabriela Hernandez-Molina, Caroline C. Horner, Robert W. Hostoffer, Nataliya Hristova, Kuang-Chih Hsiao, Gabriela Ivankovich-Escoto, Faris Jaber, Maaz Jalil, Mahnaz Jamee, Tiffany Jean, Stephanie Jeong, Devi Jhaveri, Michael B. Jordan, Avni Y. Joshi, Amanpreet Kalkat, Henry J. Kanarek, Erinn S. Kellner, Amer Khojah, Ruby Khoury, Cristina M. Kokron, Ashish Kumar, Kelsey Lecerf, Heather K. Lehman, Jennifer W. Leiding, Harry Lesmana, Xin Rong Lim, Joao Pedro Lopes, Ana Laura López, Lucia Tarquini, Ingrid S. Lundgren, Julieann Magnusson, Ana Karolina B. B. Marinho, Gian Luigi Marseglia, Giulia M. Martone, Annamaria G. Mechtler, Leonardo Mendonca, Joshua D. Milner, Peter J. Mustillo, Asal Gharib Naderi, Samuele Naviglio, Jeremy Nell, Hana B. Niebur, Luigi Notarangelo, Matias Oleastro, María Claudia Ortega-López, Neil R. Patel, Gordana Petrovic, Claudio Pignata, Oscar Porras, Benjamin T. Prince, Jennifer M. Puck, Nashmia Qamar, Marco Rabusin, Nikita Raje, Lorena Regairaz, Kimberly A. Risma, Elizabeth H. Ristagno, John Routes, Persio Roxo-Junior, Negin Salemi, Christopher Scalchunes, Susan J. Schuval, Suranjith L. Seneviratne, Ashwin Shankar, Roya Sherkat, Junghee Jenny Shin, Abeer Siddiqi, Sara Signa, Ali Sobh, Fabiana Mascarenhas Souza Lima, Kristen K. Stenehjem, Jonathan S. Tam, Monica Tang, Myrthes Toledo Barros, James Verbsky, Eleni Vergadi, Dayne H. Voelker, Stefano Volpi, Luke A. Wall, Christine Wang, Kelli W. Williams, Eveline Y. Wu, Shan Shan Wu, Jessie J. Zhou, Alexandria Cook, Kathleen E. Sullivan, Rebecca Marsh

Published in: Journal of Clinical Immunology | Issue 4/2024

Login to get access

Abstract

Background

The CDC and ACIP recommend COVID-19 vaccination for patients with inborn errors of immunity (IEI). Not much is known about vaccine safety in IEI, and whether vaccination attenuates infection severity in IEI.

Objective

To estimate COVID-19 vaccination safety and examine effect on outcomes in patients with IEI.

Methods

We built a secure registry database in conjunction with the US Immunodeficiency Network to examine vaccination frequency and indicators of safety and effectiveness in IEI patients. The registry opened on January 1, 2022, and closed on August 19, 2022.

Results

Physicians entered data on 1245 patients from 24 countries. The most common diagnoses were antibody deficiencies (63.7%). At least one COVID-19 vaccine was administered to 806 patients (64.7%), and 216 patients received vaccination prior to the development of COVID-19. The most common vaccines administered were mRNA-based (84.0%). Seventeen patients were reported to seek outpatient clinic or emergency room care for a vaccine-related complication, and one patient was hospitalized for symptomatic anemia. Eight hundred twenty-three patients (66.1%) experienced COVID-19 infection. Of these, 156 patients required hospitalization (19.0%), 47 required ICU care (5.7%), and 28 died (3.4%). Rates of hospitalization (9.3% versus 24.4%, p < 0.001), ICU admission (2.8% versus 7.6%, p = 0.013), and death (2.3% versus 4.3%, p = 0.202) in patients who had COVID-19 were lower in patients who received vaccination prior to infection. In adjusted logistic regression analysis, not having at least one COVID-19 vaccine significantly increased the odds of hospitalization and ICU admission.

Conclusion

Vaccination for COVID-19 in the IEI population appears safe and attenuates COVID-19 severity.
Literature
1.
go back to reference V’Kovski P, Kratzel A, Steiner S, Stalder H, Thiel V. Coronavirus biology and replication: implications for SARS-CoV-2. Nat Rev Microbiol. 2021;19(3):155–70.CrossRefPubMed V’Kovski P, Kratzel A, Steiner S, Stalder H, Thiel V. Coronavirus biology and replication: implications for SARS-CoV-2. Nat Rev Microbiol. 2021;19(3):155–70.CrossRefPubMed
2.
go back to reference Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239–42.CrossRefPubMed Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239–42.CrossRefPubMed
3.
go back to reference Kompaniyets L, Pennington AF, Goodman AB, Rosenblum HG, Belay B, Ko JY, et al. Underlying medical conditions and severe illness among 540,667 adults hospitalized with COVID-19, March 2020–March 2021. Preventing Chronic Disease. 2021;18. Kompaniyets L, Pennington AF, Goodman AB, Rosenblum HG, Belay B, Ko JY, et al. Underlying medical conditions and severe illness among 540,667 adults hospitalized with COVID-19, March 2020–March 2021. Preventing Chronic Disease. 2021;18.
4.
go back to reference Meyts I, Bucciol G, Quinti I, Neven B, Fischer A, Seoane E, et al. Coronavirus disease 2019 in patients with inborn errors of immunity: an international study. J Allergy Clin Immunol. 2021;147(2):520–31.CrossRefPubMed Meyts I, Bucciol G, Quinti I, Neven B, Fischer A, Seoane E, et al. Coronavirus disease 2019 in patients with inborn errors of immunity: an international study. J Allergy Clin Immunol. 2021;147(2):520–31.CrossRefPubMed
5.
go back to reference Delmonte OM, Castagnoli R, Notarangelo LD. COVID-19 and inborn errors of immunity. Physiology (Bethesda). 2022;37(6):0. Delmonte OM, Castagnoli R, Notarangelo LD. COVID-19 and inborn errors of immunity. Physiology (Bethesda). 2022;37(6):0.
6.
go back to reference Zhang Q, Bastard P, Liu Z, Le Pen J, Moncada-Velez M, Chen J, et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science. 2020;370(6515). Zhang Q, Bastard P, Liu Z, Le Pen J, Moncada-Velez M, Chen J, et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science. 2020;370(6515).
7.
go back to reference Abolhassani H, Delavari S, Landegren N, Shokri S, Bastard P, Du L, et al. Genetic and immunologic evaluation of children with inborn errors of immunity and severe or critical COVID-19. J Allergy Clin Immunol. 2022. Abolhassani H, Delavari S, Landegren N, Shokri S, Bastard P, Du L, et al. Genetic and immunologic evaluation of children with inborn errors of immunity and severe or critical COVID-19. J Allergy Clin Immunol. 2022.
8.
go back to reference Ferre EMN, Schmitt MM, Ochoa S, Rosen LB, Shaw ER, Burbelo PD, et al. SARS-CoV-2 spike protein-directed monoclonal antibodies may ameliorate COVID-19 complications in APECED patients. Front Immunol. 2021;12: 720205.CrossRefPubMedPubMedCentral Ferre EMN, Schmitt MM, Ochoa S, Rosen LB, Shaw ER, Burbelo PD, et al. SARS-CoV-2 spike protein-directed monoclonal antibodies may ameliorate COVID-19 complications in APECED patients. Front Immunol. 2021;12: 720205.CrossRefPubMedPubMedCentral
9.
go back to reference Tangye SG, consortium CHGE. Impact of SARS-CoV-2 infection and COVID-19 on patients with inborn errors of immunity. J Allergy Clin Immunol. 2023;151(4):818–31.CrossRefPubMed Tangye SG, consortium CHGE. Impact of SARS-CoV-2 infection and COVID-19 on patients with inborn errors of immunity. J Allergy Clin Immunol. 2023;151(4):818–31.CrossRefPubMed
10.
go back to reference Bergman P, Blennow O, Hansson L, Mielke S, Nowak P, Chen P, et al. Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial. EBioMedicine. 2021;74: 103705.CrossRefPubMedPubMedCentral Bergman P, Blennow O, Hansson L, Mielke S, Nowak P, Chen P, et al. Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial. EBioMedicine. 2021;74: 103705.CrossRefPubMedPubMedCentral
11.
go back to reference Pulvirenti F, Fernandez Salinas A, Milito C, Terreri S, Piano Mortari E, Quintarelli C, et al. B cell response induced by SARS-CoV-2 infection is boosted by the BNT162b2 vaccine in primary antibody deficiencies. Cells. 2021;10(11). Pulvirenti F, Fernandez Salinas A, Milito C, Terreri S, Piano Mortari E, Quintarelli C, et al. B cell response induced by SARS-CoV-2 infection is boosted by the BNT162b2 vaccine in primary antibody deficiencies. Cells. 2021;10(11).
12.
go back to reference Gernez Y, Murugesan K, Cortales CR, Banaei N, Hoyte L, Pinsky BA, et al. Immunogenicity of a third COVID-19 messenger RNA vaccine dose in primary immunodeficiency disorder patients with functional B-cell defects. J Allergy Clin Immunol Pract. 2022;10(5):1385-8 e2.CrossRefPubMedPubMedCentral Gernez Y, Murugesan K, Cortales CR, Banaei N, Hoyte L, Pinsky BA, et al. Immunogenicity of a third COVID-19 messenger RNA vaccine dose in primary immunodeficiency disorder patients with functional B-cell defects. J Allergy Clin Immunol Pract. 2022;10(5):1385-8 e2.CrossRefPubMedPubMedCentral
13.
go back to reference Delmonte OM, Bergerson JRE, Burbelo PD, Durkee-Shock JR, Dobbs K, Bosticardo M, et al. Antibody responses to the SARS-CoV-2 vaccine in individuals with various inborn errors of immunity. J Allergy Clin Immunol. 2021;148(5):1192–7.CrossRefPubMedPubMedCentral Delmonte OM, Bergerson JRE, Burbelo PD, Durkee-Shock JR, Dobbs K, Bosticardo M, et al. Antibody responses to the SARS-CoV-2 vaccine in individuals with various inborn errors of immunity. J Allergy Clin Immunol. 2021;148(5):1192–7.CrossRefPubMedPubMedCentral
15.
go back to reference Dan J, da Silva Antunes R, Grifoni A, Weiskopf D, Crotty S, Sette A. Observations and perspectives on adaptive immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis. 2022;75(Supplement_1):S24–9.CrossRefPubMed Dan J, da Silva Antunes R, Grifoni A, Weiskopf D, Crotty S, Sette A. Observations and perspectives on adaptive immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis. 2022;75(Supplement_1):S24–9.CrossRefPubMed
16.
go back to reference Pham MN, Murugesan K, Banaei N, Pinsky BA, Tang M, Hoyte E, et al. Immunogenicity and tolerability of COVID-19 messenger RNA vaccines in primary immunodeficiency patients with functional B-cell defects. Journal of Allergy and Clinical Immunology. 2022;149(3):907-11.e3.CrossRefPubMed Pham MN, Murugesan K, Banaei N, Pinsky BA, Tang M, Hoyte E, et al. Immunogenicity and tolerability of COVID-19 messenger RNA vaccines in primary immunodeficiency patients with functional B-cell defects. Journal of Allergy and Clinical Immunology. 2022;149(3):907-11.e3.CrossRefPubMed
17.
go back to reference Di Fusco M, Moran MM, Cane A, Curcio D, Khan F, Malhotra D, et al. Evaluation of COVID-19 vaccine breakthrough infections among immunocompromised patients fully vaccinated with BNT162b2. J Med Econ. 2021;24(1):1248–60.CrossRefPubMed Di Fusco M, Moran MM, Cane A, Curcio D, Khan F, Malhotra D, et al. Evaluation of COVID-19 vaccine breakthrough infections among immunocompromised patients fully vaccinated with BNT162b2. J Med Econ. 2021;24(1):1248–60.CrossRefPubMed
18.
go back to reference Cousins K, DeFelice N, Jeong S, Feng J, Lee ASE, Rotella K, et al. SARS-COV-2 infections in inborn errors of immunity: a single center study. Front Immunol. 2022;13:1035571.CrossRefPubMedPubMedCentral Cousins K, DeFelice N, Jeong S, Feng J, Lee ASE, Rotella K, et al. SARS-COV-2 infections in inborn errors of immunity: a single center study. Front Immunol. 2022;13:1035571.CrossRefPubMedPubMedCentral
19.
go back to reference Shimabukuro TT, Cole M, Su JR. Reports of anaphylaxis after receipt of mRNA COVID-19 vaccines in the US-December 14, 2020-January 18, 2021. JAMA. 2021;325(11):1101–2.CrossRefPubMedPubMedCentral Shimabukuro TT, Cole M, Su JR. Reports of anaphylaxis after receipt of mRNA COVID-19 vaccines in the US-December 14, 2020-January 18, 2021. JAMA. 2021;325(11):1101–2.CrossRefPubMedPubMedCentral
20.
go back to reference Oster ME, Shay DK, Su JR, Gee J, Creech CB, Broder KR, et al. Myocarditis cases reported after mRNA-based COVID-19 vaccination in the US from December 2020 to August 2021. JAMA. 2022;327(4):331–40.CrossRefPubMedPubMedCentral Oster ME, Shay DK, Su JR, Gee J, Creech CB, Broder KR, et al. Myocarditis cases reported after mRNA-based COVID-19 vaccination in the US from December 2020 to August 2021. JAMA. 2022;327(4):331–40.CrossRefPubMedPubMedCentral
21.
go back to reference Cetin Gedik K, Lamot L, Romano M, Demirkaya E, Piskin D, Torreggiani S, et al. The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology points to consider for diagnosis and management of autoinflammatory type I interferonopathies: CANDLE/PRAAS, SAVI and AGS. Ann Rheum Dis. 2022;81(5):601–13.CrossRefPubMed Cetin Gedik K, Lamot L, Romano M, Demirkaya E, Piskin D, Torreggiani S, et al. The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology points to consider for diagnosis and management of autoinflammatory type I interferonopathies: CANDLE/PRAAS, SAVI and AGS. Ann Rheum Dis. 2022;81(5):601–13.CrossRefPubMed
22.
go back to reference Bousfiha A, Moundir A, Tangye SG, Picard C, Jeddane L, Al-Herz W, et al. The 2022 update of IUIS phenotypical classification for human inborn errors of immunity. J Clin Immunol. 2022;42(7):1508–20.CrossRefPubMed Bousfiha A, Moundir A, Tangye SG, Picard C, Jeddane L, Al-Herz W, et al. The 2022 update of IUIS phenotypical classification for human inborn errors of immunity. J Clin Immunol. 2022;42(7):1508–20.CrossRefPubMed
23.
go back to reference Johns Hopkins Coronavirus Resource Center - Data Visualizations. Johns Hopkins Coronavirus Resource Center - Data Visualizations.
24.
go back to reference Drzymalla E, Green RF, Knuth M, Khoury MJ, Dotson WD, Gundlapalli A. COVID-19-related health outcomes in people with primary immunodeficiency: a systematic review. Clin Immunol. 2022:109097. Drzymalla E, Green RF, Knuth M, Khoury MJ, Dotson WD, Gundlapalli A. COVID-19-related health outcomes in people with primary immunodeficiency: a systematic review. Clin Immunol. 2022:109097.
25.
go back to reference Shields AM, Burns SO, Savic S, Richter AG, Consortium UPC-. COVID-19 in patients with primary and secondary immunodeficiency: the United Kingdom experience. J Allergy Clin Immunol. 2021;147(3):870–5 e1. Shields AM, Burns SO, Savic S, Richter AG, Consortium UPC-. COVID-19 in patients with primary and secondary immunodeficiency: the United Kingdom experience. J Allergy Clin Immunol. 2021;147(3):870–5 e1.
26.
go back to reference Milito C, Lougaris V, Giardino G, Punziano A, Vultaggio A, Carrabba M, et al. Clinical outcome, incidence, and SARS-CoV-2 infection-fatality rates in Italian patients with inborn errors of immunity. J Allergy Clin Immunol Pract. 2021;9(7):2904-6 e2.CrossRefPubMedPubMedCentral Milito C, Lougaris V, Giardino G, Punziano A, Vultaggio A, Carrabba M, et al. Clinical outcome, incidence, and SARS-CoV-2 infection-fatality rates in Italian patients with inborn errors of immunity. J Allergy Clin Immunol Pract. 2021;9(7):2904-6 e2.CrossRefPubMedPubMedCentral
27.
28.
go back to reference Pergent M, Haerynck F, Hoste L, Gardulf A. COVID-19 vaccination in patients with primary immunodeficiencies: an international survey on patient vaccine hesitancy and self-reported adverse events. Front Immunol. 2023;14:1166198.CrossRefPubMedPubMedCentral Pergent M, Haerynck F, Hoste L, Gardulf A. COVID-19 vaccination in patients with primary immunodeficiencies: an international survey on patient vaccine hesitancy and self-reported adverse events. Front Immunol. 2023;14:1166198.CrossRefPubMedPubMedCentral
Metadata
Title
COVID-19 Vaccination in Patients with Inborn Errors of Immunity Reduces Hospitalization and Critical Care Needs Related to COVID-19: a USIDNET Report
Authors
John McDonnell
Kimberley Cousins
M. Elizabeth M. Younger
Adam Lane
Hassan Abolhassani
Roshini S. Abraham
Salem Al-Tamemi
Juan Carlos Aldave-Becerra
Eman Hesham Al-Faris
Alberto Alfaro-Murillo
Suzan A. AlKhater
Nouf Alsaati
Alexa Michelle Altman Doss
Melissa Anderson
Ernestina Angarola
Barbara Ariue
Danielle E. Arnold
Amal H. Assa’ad
Caner Aytekin
Meaghan Bank
Jenna R. E. Bergerson
Jack Bleesing
John Boesing
Carolina Bouso
Nicholas Brodszki
Diana Cabanillas
Carol Cady
Meghan A. Callahan
Roberta Caorsi
Javier Carbone
Maria Carrabba
Riccardo Castagnoli
Jason R. Catanzaro
Samantha Chan
Sharat Chandra
Hugo Chapdelaine
Zahra Chavoshzadeh
Hey Jin Chong
Lori Connors
Filippo Consonni
Oscar Correa-Jimenez
Charlotte Cunningham-Rundles
Katherine D’Astous-Gauthier
Ottavia Maria Delmonte
Yesim Yilmaz Demirdag
Deepti R. Deshpande
Natalie M. Diaz-Cabrera
Victoria R. Dimitriades
Rasha El-Owaidy
Gehad ElGhazali
Suleiman Al-Hammadi
Giovanna Fabio
Astrid Schellnast Faure
Jin Feng
James M. Fernandez
Lauren Fill
Guacira R. Franco
Robert W. Frenck
Ramsay L. Fuleihan
Giuliana Giardino
Jessica Galant-Swafford
Eleonora Gambineri
Elizabeth K. Garabedian
Ashley V. Geerlinks
Ekaterini Goudouris
Octavio Grecco
Qiang Pan-Hammarström
Hedieh Haji Khodaverdi Khani
Lennart Hammarström
Nicholas L. Hartog
Jennifer Heimall
Gabriela Hernandez-Molina
Caroline C. Horner
Robert W. Hostoffer
Nataliya Hristova
Kuang-Chih Hsiao
Gabriela Ivankovich-Escoto
Faris Jaber
Maaz Jalil
Mahnaz Jamee
Tiffany Jean
Stephanie Jeong
Devi Jhaveri
Michael B. Jordan
Avni Y. Joshi
Amanpreet Kalkat
Henry J. Kanarek
Erinn S. Kellner
Amer Khojah
Ruby Khoury
Cristina M. Kokron
Ashish Kumar
Kelsey Lecerf
Heather K. Lehman
Jennifer W. Leiding
Harry Lesmana
Xin Rong Lim
Joao Pedro Lopes
Ana Laura López
Lucia Tarquini
Ingrid S. Lundgren
Julieann Magnusson
Ana Karolina B. B. Marinho
Gian Luigi Marseglia
Giulia M. Martone
Annamaria G. Mechtler
Leonardo Mendonca
Joshua D. Milner
Peter J. Mustillo
Asal Gharib Naderi
Samuele Naviglio
Jeremy Nell
Hana B. Niebur
Luigi Notarangelo
Matias Oleastro
María Claudia Ortega-López
Neil R. Patel
Gordana Petrovic
Claudio Pignata
Oscar Porras
Benjamin T. Prince
Jennifer M. Puck
Nashmia Qamar
Marco Rabusin
Nikita Raje
Lorena Regairaz
Kimberly A. Risma
Elizabeth H. Ristagno
John Routes
Persio Roxo-Junior
Negin Salemi
Christopher Scalchunes
Susan J. Schuval
Suranjith L. Seneviratne
Ashwin Shankar
Roya Sherkat
Junghee Jenny Shin
Abeer Siddiqi
Sara Signa
Ali Sobh
Fabiana Mascarenhas Souza Lima
Kristen K. Stenehjem
Jonathan S. Tam
Monica Tang
Myrthes Toledo Barros
James Verbsky
Eleni Vergadi
Dayne H. Voelker
Stefano Volpi
Luke A. Wall
Christine Wang
Kelli W. Williams
Eveline Y. Wu
Shan Shan Wu
Jessie J. Zhou
Alexandria Cook
Kathleen E. Sullivan
Rebecca Marsh
Publication date
01-04-2024
Publisher
Springer US
Published in
Journal of Clinical Immunology / Issue 4/2024
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-023-01613-5

Other articles of this Issue 4/2024

Journal of Clinical Immunology 4/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.